UK OTC Industry Welcomes Post-Brexit Drug Import Batch Testing Solution
Executive Summary
UK consumer healthcare industry association, PAGB welcomes the UK government's recent announcement that its policy of not requiring domestic batch testing or certification of medicines imported from the EU/European Economic Area is to be made permanent.
You may also be interested in...
Industry Breathes Sigh Of Relief Over UK Batch Release Move
One of the key regulatory conundrums thrown up by Brexit has been addressed after the government decided to continue using a list of approved countries to waive drug import testing requirements.
EU OTC Batch Testing Will Continue To Be Accepted In UK, For Now
Recognition of EU/EEA batch testing of imported medicines by UK will not be ending on 1 January 2023, and companies will be given two years notice if anything changes, says MHRA.
OTC Shortages Top Of Mind For North American, European and Asia Pacific Consumers
An overwhelming majority of consumers surveyed by IT consultancy Capgemini are concerned they will not be able to obtain the OTC health products they require or want. In the event of shortages – which are currently affecting consumers across Europe – many respondents said they would substitute with another brand, or in some cases not purchase at all.